Surgical Hepatobiliary Diseases
|
|
- Verity Caitlin Parrish
- 6 years ago
- Views:
Transcription
1 Case 1 Surgical Hepatobiliary Diseases M. Sinanan MD, PhD 48 yo WF with RUQ, postprandial pain, fever, nausea, vomiting, and tenderness. US and HIDA done Issues Interpretation Adequate WU? 2 Normal Studies Case 1 48 yo WF with RUQ, postprandial pain, tenderness, and US and HIDA done Issues Interpretation? Ultrasound Gallbladder with gallstone dz 3 Case 1 Gallstone Disease I 48 yo WF with RUQ, postprandial pain, nausea, vomiting, fever, and tenderness. US + for GB wall edema, pericholecystic fluid, no gallstones seen HIDA + for cystic duct obstruction Dx: Acute cholecystitis. Cause? Adequate WU? Indication for surgery? Options for management Risks of surgery Consent Technical issues in procedure Consequences of treatment Prevalence: 20% US population (52M in US) Female, middle aged, postpartum, + FH Issues NA population increased prevalence 90% cholesterol, 10% pigment in character 50% symptomatic, 20% over 20 yr rate of becoming symptomatic Symptoms tend to be similar to presentation Once gallstones are present, they persist Once symptomatic, always symptomatic Complications of gallstone disease: acute cholecystitis, CBD obstruction, pancreatitis, cholecystoduodenal fistula, GB cancer 6
2 Gallstone Disease II History LFT s US Bili <3, elevated alk phos, normal ALT/AST CBD railroad tracks Gallstones GB size, thickness of wall, pericholecystic fluid CBD diameter Indicates function of GB, tracer uptake, biliary tract anatomy, drainage Non-filling GB acute cholecystitis EF <40% with CCK chronic cholecystitis Rx Gallstones with acustic shadow HIDA scan US Images of Gallstone Disease Diagnosis Cholecystectomy (laparoscopic, open) Ursodeoxycholic acid Actigall (1-3 gallstones, < 1 cm diameter, noncalcified) Lithotripsy Cholecystostomy (acute cholecystitis in surgically unfit patient) Consequences of cholecystectomy 50% have looser BM s initially, will correct for most but 3-5% suffer long term with diarrhea Bile leak, biliary tract injury 0.3% 7 Laparoscopic Cholangiogram: Normal Anatomy 8 Images: Lap Chole for Acute Cholecystitis Steps in procedure Case 1: Outcome Lap chole for Acute cholecystitis Variations in Biliary Anatomy Acute, necrotizing cholecystitis 11 Bile Duct Variation Hepatic Artery Variation 12
3 Choledocholithiasis p 95% of CBD stones from GB p Untreated, 80% chance of complications: biliary obstruction, cholangitis, pancreatitis p Management: always resolve 1. Endoscopic ERCP 2. Laparoscopic/open CBD exploration during chole 3. Transhepatic cholangiography - PTC p Primary CBD stones pigment n Associated with biliary obstruction, stasis, foreign body n Oriental cholangiohepatitis At laparoscopy At ERCP Case 2 p 61 yo BM with 5 kg wt loss, dark urine, clay-colored stools but no pain. Afebrile. Jaundice, mild RUQ tenderness and fullness on clinical exam. No other physical findings. n Labs p LFT s: T. Bili 8, Alk Phos 680, ALT 140, AST 160, amylase 27. n Next step? US Normal liver Case 2: Studies p Hepatitis serology p US Case 2: Studies Normal ERCP p US p CT Scan 17 18
4 Case 2: Studies Normal MRI Biliary Tract p US p CT p ERCP Studies p US p CT p ERCP p MRCP Studies p US p CT p ERCP p MRCP n vs adjacent vessels Case 2 p 61 yo WM with wt loss, dark urine, claycolored stools but no pain n LFT Bili 8, Alk Phos 600, ALT 80, AST 45 p Issues n DDx n Evaluation n Radiographic studies n Curative vs noncurative n Natural history of each treatment option n Surgical options 23 Painless jaundice: DDx p Indirect bili elevation, no ductal dilation n Hepatitis liver failure (usually associated symptoms) p Direct bili elevation, no ductal dilation n Sclerosing cholangitis n Early obstruction p Direct bili elevation, ductal dilation n Choledocholithiasis with obstruction n Periampullary malignancy p Pancreatic adenoca p Distal cholangiocarcinoma p Ampullary adenoca p Duodenal adenoca n Klatskin s, CBD, CHD tumor n RHD or LHD tumor with significant liver dysfunction n Other 24
5 Pattern of Extrahepatic Cholangiocarcinoma Biliary Anatomy Gallbladder cancer 2-9X more common than ductal cholangioca #1 # Prevalence % of extrahepatic cholangioca 8-13% 10-26% # % #3 6% # % Gallbladder Cancer p Present in 1/200 to 1/500 cholecystectomy specimens p High association with gallstones p Preop Dx n Continuous pain n RUQ mass by palpation, mass in GB on US n Porcelain gallbladder p Intraop n Inflammation out of proportion to history n Hepatic invasion p Postoperative n Pathology p Stage 1-2 potentially cured with cholecystectomy n Liver wedge resection and porta lympadenectomy for Stage 2 n Port site recurrences p Stage 3-4 n Incurable n 3-6 mo median survival n Chemo and XRT-unresponsive 27 Gallbladder Cancer Staging and Survival Staging (TNM) Stage Survival % (5 yr) 1 75 Stage T N M T1-2,N1 T3,N a T4 N b Tany Tany N2 Any Most patient present in Stage 3 or 4 28 Hilar Cholangiocarcinoma (Klatskin s Tumor- Case 2) 29 p Dx Extrahepatic Ductal Cholangiocarcinoma n W/U pruritis, jaundice n US, CT, ERCP, EUS and biopsies (brushings) n Visible mass by preop studies is poor prognostic finding as it usually indicates local extension into porta structures rendering the lesion unresectable p Rx n Resection - <10% resectable for cure n ChemoXRT Equivocal benefit n Luminal XRT (Brachytherapy) experimental n Palliative - Wallstent 30
6 Case 3 p 54 yo female n H/O Hepatitis C n Increased fatigue, RUQ pain and tenderness n Intermittent confusion noted by family n Exam shows jaundice, ascites. n W/U? Case 3 p 54 yo female n H/O Hepatitis C n Increased fatigue, RUQ pain n W/U p LFT s ALT 100, AST 100, Bili 2.8, Albumin 2.5, INR 2.2 p AFP (nonmaternal) 5 (6 mos ago) rising to US Normal liver Case 3: US Margin of mass Mass CT Normal Liver Case 3: CT Scan Non-contrast Arterial phase Portal vein invasion PV phase 35 36
7 Case 3 p 54 yo female n H/O Hepatitis C n Increased fatigue, RUQ pain n W/U p LFT s ALT 100, AST 100, Bili 2.8, Albumin 2.5, INR 2.2 p US Cirrhosis liver masses, bilobar p CT Hypervascular, multifocal masses with right PV invasion p AFP (nonmaternal) Case 3: Multifocal HCC in Cirrhosis Lesion Appearance Dx:HCC in Hep C-associated cirrhosis Options for Management? (6 mos ago) rising to 2000 p p p p p Hepatitis C (HCV): Overview Leading cause of chronic liver dz US (prevalence 1.4% US population) Transmission: IVDA, transfusions, sexual transmission Most common indication for liver transplantation RNA virus, 4M infections in US, 170M worldwide Natural History n 20-35% progress to cirrhosis n 2-5% of cirrhotics develop HCC per year n 50% of HCV carriers +cirrhosis develop HCC n Timing 10 yr to clinical liver dz 21.2 yr to cirrhosis 29 yr to HCC p Cirrhosis n Survival HCV: Cirrhosis p Compensated dz (CPT 5-9, Child s A and B) 90% 5 yr, 80% 10 yr p Uncompensated dz (CPT >9, Child s C) 50% 5 yr Transplant group p Rx: peginterferon alpha and ribavirin eliminates virus in 55% patients Hepatocellular Ca (HCC) - 1 Resection: Gold standard for lesion eradication p Incidence: World-wide very common 560,000 new cases/yr n SE Asia, Sub-Saharan Africa 52/100,000 n NA and Europe 2.5/100,000 p Risk factors chronic liver dz Hep B & C, EtOH p Dx at risk individual, mass, AFP, bx p Resectable dz n 40-50% 5 yr dz free survival but only 10-20% are candidates for resection p Recurrence n satellite nodules or multicentric foci in liver p Resection 40-50% 5 yr dz free survival p Only 30% are resectable for cure p Issues: Resectability, hepatic reserve n Resectability pattern/extent of dz p Staging (US, CT, MR, PET) p Consider preop treatment (RFA, PV embolization) p Segmental vs lobar resection, limiting intraop ischemic injury to liver n Hepatic reserve p Child-Pugh score p 3D reconstruction of liver for assessment of % residual volume (35% normal liver for survival) p Clearance studies (ICG or lidocaine) p Portal-hepatic venous gradient n regional LN, lungs, bone, adrenal 41 42
8 CT Criteria for Hepatic Segmentation Hepatic Vascular Anatomy Hepatic artery 3D reconstruction Portal vein Spiral CT Issues in Hepatic Resection: Control of Bleeding p Hepatic blood flow n 20% of CO to liver n 2/3 in PV (1/3 O 2 ), 1/3 in HA (2/3 O 2 ) p Procedural steps n Mapping lesion and vascular anatomy - IOUS n Dissection of porta n Vascular control/isolation p PV, HA to resected area divided p inflow occlusion (Pringle) p Hepatic vein occlusion (outflow occlusion) p Liver isolation: Heaney maneuver n Parenchymal dissection along anatomic lines p Ligasure p Stapler p Clips and ties Liver resection Hepatic Anatomy Resection: Gold standard for lesion eradication 47 p Resection 40-50% 5 yr dz free survival p Only 30% are resectable for cure p Issues: Resectability, hepatic reserve n Resectability pattern/extent of dz p Staging (US, CT, MR, PET) p Consider preop treatment (RFA, PV embolization) p Segmental vs lobar resection, limiting intraop ischemic injury to liver n Hepatic reserve p Child-Pugh score p 3D reconstruction of liver for assessment of % residual volume (35% normal liver for survival) p Clearance studies (ICG or lidocaine) p Portal-hepatic venous gradient 48
9 Score Child-Pugh-Turcott (CPT) Score Bili (mg/ dl) Albumin (gm/dl) PT (sec) Hepatic Encephal Ascites (grade) 1 <2 > None None Mild 3 >3 < 2.8 >6 3-4 Severe Sum Score Child s Class Survival (%, 1 yr) 5-6 A B 70 Alternatives to Liver Resection p Transplantation (for HCC, selected pts) p Embolization n Lipiodol n Chemoembolization p Ablation n Radiofrequency energy n Ethanol n Cryotherapy n Acetic Acid p Radiation n Confocal radiation > 9 C n Yttrium microspheres (Theraspheres TM ) RFA p Indications: n No evidence of extrahepatic tumor n Less than 5 cm in diameter n Not in proximity to portal triad Transplantation for HCC MELD Feb 2002 Implementation p Criteria (highly selected patients): n One HCC nodule up to 5 cm, OR n Up to 3 lesions (all < 3 cm) n No extrahepatic spread, vascular involvement, not a resection candidate p Survival n 83% at 3 yr Liver Mass Biopsy + Suspicious: AFP cirrhosis Hepatocellular Carcinoma Extent of Disease -multiphase CT -lipiodol CT -MRI Limited Disease 1 5 cm 3 3 cm ØPV thrombosis Extensive Disease >5 cm or >3 lesions PV thrombosis Metastases 53 Hepatocellular Carcinoma Limited Disease 1 5 cm 3 3 cm ØPV thrombosis Extensive Disease >5 cm or >3 lesions PV thrombosis Metastases Hepatic Reserve Child s A Child s B Child s C Wedge Pressure Gradient Other factor: Platelet count <10 >10 54
10 Limited Disease Hepatic Reserve Child s A Child s B Child s C Hepatocellular Carcinoma Wedge <10 Pressure Gradient >10 Performance Status Good Poor Transplant candidate yes Tumor -near limit -progressive no Resection Ablation Transplantation Bridging Rx Ablation Chemo TACE Ablation Chemo XRT TACE Supportive Care 55 Hepatocellular Carcinoma Extensive Disease >5 cm or >3 lesions PV thrombosis Metastases Hepatic Reserve Child s A Child s B Child s C Performance Status Wedge <10 Pressure Gradient >10 Resection Ablation Chemo XRT TACE Supportive Care 56 Metastatic Disease to the Liver p Treatable lesions (for cure, or for palliation of hormonal secretory function) n Colorectal metastases n Carcinoid n Islet tumors n Breast ca? p Characteristics n Isolated to liver n Adequate residual parenchyma and liver function CRC: Metastatic Liver Tumors p 15-25% of patients with colorectal cancer (CRC) have liver metastases at time of dx p 20% of CRC patients develop metachronous liver lesions p 25% of CRC patients have isolated liver metastases n 10-25% are resectable for cure n Survival: 25-35% at 5 years Benign Hepatic Tumors p Hepatic cysts Focal Nodular Hyperplasia p Biliary cystadenomas p Hemangiomas p Focal nodular hyperplasia p Hepatic adenoma 59 60
11 Hepatic Adenoma Case 4 p 58 yo WM, former alcoholic n Symptoms of forgetfulness, fatigue, abdominal distension n Exam shows palmar erythemia, gynecomastia, spider angiomata, distended abd with ascites, jaundice, muscle wasting n Evaluation? Case 4 p Labs n Hepatitis screen n LFT s, albumin, INR, platelet count n AFP p Films n US portal vein, liver n CT liver, spleen, ascites p Assessment: Hepatic reserve n Cumulative hepatic volume n CPT score CT Scan p Findings n Shrunken liver n Irregular contour n Perigastric prominent vasculature n Splenomegaly p Dx: Advanced cirrhosis and portal hypertension Clinical Manifestations of Portal Hypertension Physiology: Critical Functions p Synthesis n Albumin n Clotting factors n Plasma proteins n Cholesterol/bile salts for digestion p Regulation n Aminoacid metabolism p Energy metabolism n Glycogen - gluconeogenesis p Detoxification n Ammonia to urea for excretion n drugs, metabolites (i.e. octopamine) p Excretion n Bile p Immunological n Bacterial filter, regulation immune response to infection 65 66
12 Clinical Consequences of Portal Hypertension (PH) p Definition n portal vein pressure >10-13 mm Hg (57% sensitivity, 100% specificity) p Natural History n Most (90%) cirrhotics develop PH eventually n Only 20-30% bleed n Most (80%) of bleeding episodes stop spontaneously n Most (50-70%) rebleeding (1-2 yr) n 1 in 3 dies from complications of first bleeding episode n 50% - 5 yr survival with cirrhosis + PV 67 Portal Hypertension: Medical Rx p Supportive measures (stop EtOH) p Medical Rx: Beta blocker p Banding/sclerosis for bleeding esophageal varices 68 Portal Hypertension: Rx p Supportive measures (stop EtOH) p Medical Rx: Beta blocker p Banding/sclerosis for bleeding esophageal varices p Portcaval shunt n TIPSS (transjugular intrahepatic portosystemic shunt) n Portacaval shunt (nonselective) p Liver transplantation for decompensation and/or complications Portal Venous anatomy 69 Survival after Liver Transplant for Cirrhosis and End Stage Liver Failure UNOS 2001 Annual Report Graft Survival Patient Survival # Pts 1 Year % 5 Year % Summary p Surgical Hepatobiliary Disorders n Biliary p Gallstone disease p Biliary tumors p (Cystic diseases of biliary tree) n Liver p Liver tumors Primary malignancy Role of Hep C Secondary malignancy Benign tumors p Liver failure Portal hypertension and complications Liver failure assessment and definitive Rx Transplantation 71
Imaging of liver and pancreas
Imaging of liver and pancreas.. Disease of the liver Focal liver disease Diffusion liver disease Focal liver disease Benign Cyst Abscess Hemangioma FNH Hepatic adenoma HCC Malignant Fibrolamellar carcinoma
More informationRadiology of hepatobiliary diseases
GI cycle - Lecture 14 436 Teams Radiology of hepatobiliary diseases Objectives 1. To Interpret plan x-ray radiograph of abdomen with common pathologies. 2. To know the common pathologies presentation.
More informationLIVER. Question 1 ~ Anatomy. Answer 1 ~ Anatomy 1/5/2018. SEMCME Board Review January 11-12, 2017
SEMCME Board Review January 11-12, 2017 Surgical Treatment of Hepatobiliary and Splenic Disorders Michael J. Jacobs, MD, FACS, FICS Clinical Professor of Surgery- MSU CHM Associate Chair of Surgery Director
More informationSurgical Treatment of Hepatobiliary and Splenic Disorders
SEMCME Board Review January 10-11, 2019 Surgical Treatment of Hepatobiliary and Splenic Disorders Michael J. Jacobs, MD, FACS, FICS Clinical Professor of Surgery- MSU CHM Associate Chair of Surgery Director
More informationHepatocellular Carcinoma: Diagnosis and Management
Hepatocellular Carcinoma: Diagnosis and Management Nizar A. Mukhtar, MD Co-director, SMC Liver Tumor Board April 30, 2016 1 Objectives Review screening/surveillance guidelines Discuss diagnostic algorithm
More informationJaundice. Agnieszka Dobrowolska- Zachwieja, MD, PhD
Jaundice Agnieszka Dobrowolska- Zachwieja, MD, PhD Jaundice definition Jaundice, as in the French jaune, refers to the yellow discoloration of the skin. It arises from the abnormal accumulation of bilirubin
More informationApproach to the Patient with Liver Disease
Approach to the Patient with Liver Disease Diagnosis of liver disease Careful history taking Physical examination Laboratory tests Radiologic examination and imaging studies Liver biopsy Liver diseases
More informationVesalius SCALpel : Biliary (see also: biliary/pancreatic folios) Physiology
Vesalius SCALpel : Biliary (see also: biliary/pancreatic folios) Physiology 95% of bile acids reabsorbed; colic and chenodeoxycolic primary bile acids cholecystokinin (CCK) major stimulus of gallbladder
More informationLiverGroup.org. Case Report Form (CRF) for STAGED procedures
Case Report Form (CRF) for STAGED procedures Patient Characteristics Case number * Age * ( 18)y Gender * Male Female Race * Caucasian Asian African Other If other race, please specify Height * cm Weight
More informationA Review of Liver Function Tests. James Gray Gastroenterology Vancouver
A Review of Liver Function Tests James Gray Gastroenterology Vancouver Copyright 2017 by Sea Courses Inc. All rights reserved. No part of this document may be reproduced, copied, stored, or transmitted
More informationResident Teaching Conference:
Resident Teaching Conference: Evaluation of the Dreaded Liver Mass May 6, 2011 Sunil Geevarghese, MD, HS 00 Matt Landman, MD Anatomy Overview Couinaud anatomy Resection nomenclature Functional Assessment
More informationPrimary Sclerosing Cholangitis and Cholestatic liver diseases. Ahsan M Bhatti MD, FACP Bhatti Gastroenterology Consultants
Primary Sclerosing Cholangitis and Cholestatic liver diseases Ahsan M Bhatti MD, FACP Bhatti Gastroenterology Consultants I have nothing to disclose Educational Objectives What is PSC? Understand the cholestatic
More informationHepatobiliary and Pancreatic Malignancies
Hepatobiliary and Pancreatic Malignancies Gareth Eeson MD MSc FRCSC Surgical Oncologist and General Surgeon Kelowna General Hospital Interior Health Consultant, Surgical Oncology BC Cancer Agency Centre
More informationLiver Tumors. Prof. Dr. Ahmed El - Samongy
Liver Tumors Prof. Dr. Ahmed El - Samongy Objective 1. Identify the most important features of common benign liver tumors 2. Know the risk factors, diagnosis, and management of hepatocellular carcinoma
More informationManagement of Cholangiocarcinoma. Roseanna Lee, MD PGY-5 Kings County Hospital
Management of Cholangiocarcinoma Roseanna Lee, MD PGY-5 Kings County Hospital Case Presentation 37 year old male from Yemen presented with 2 week history of epigastric pain, anorexia, jaundice and puritis.
More informationManagement of Gallbladder Disease
Management of Gallbladder Disease Steven B. Johnson, MD, FACS, FCCM Professor and Chairman, Department of Surgery Program Director, Phoenix Integrated Surgical Residency University of Arizona College of
More informationPost-operative complications following hepatobiliary surgery: imaging findings and current radiological treatment options
Post-operative complications following hepatobiliary surgery: imaging findings and current radiological treatment options Poster No.: C-1501 Congress: ECR 2015 Type: Educational Exhibit Authors: A. Hadjivassiliou,
More informationGALLBLADDER CANCER. Lidie M. Lajoie MD Downstate Surgery M&M July 21, 2011
GALLBLADDER CANCER Lidie M. Lajoie MD Downstate Surgery M&M July 21, 2011 Agenda Case Presentation Epidemiology Pathogenesis & Pathology Staging Presentation & Diagnosis Stage-wise Management Outcomes/Prognosis
More informationManagement of Gallbladder Disease. Cory Buschmann, MD PGY-5 11/28/2017
Management of Gallbladder Disease Cory Buschmann, MD PGY-5 11/28/2017 Financial disclosures None Content Scope of gallbladder diseases Evaluation H&P Labs Imaging Cholecystectomy vs cholecystostomy Ancillary
More informationInterventional Radiology in Liver Cancer. Nakarin Inmutto MD
Interventional Radiology in Liver Cancer Nakarin Inmutto MD Liver cancer Primary liver cancer Hepatocellular carcinoma Cholangiocarcinoma Metastasis Interventional Radiologist Diagnosis Imaging US / CT
More informationBiliary MRI w Eovist
Biliary MRI w Eovist Is there any added value? Elmar M. Merkle, MD Director of MR Imaging Duke University Medical Center elmar.merkle@duke.edu Declaration of Conflict of Interest or Relationship Research
More informationHepatobiliary Malignancies Retrospective Study at Truman Medical Center
Hepatobiliary Malignancies 206-207 Retrospective Study at Truman Medical Center Brandon Weckbaugh MD, Prarthana Patel & Sheshadri Madhusudhana MD Introduction: Hepatobiliary malignancies are cancers which
More informationA patient with an unusual congenital anomaly of the pancreaticobiliary tree
A patient with an unusual congenital anomaly of the pancreaticobiliary tree Thomas Hocker, HMS IV BIDMC Core Radiology Case Presentation September 17, 2007 Review of Normal Pancreaticobiliary Tract Anatomy
More informationNewcastle HPB MDM updated radiology imaging protocol recommendations. Author Dr John Scott. Consultant Radiologist Freeman Hospital
Newcastle HPB MDM updated radiology imaging protocol recommendations Author Dr John Scott. Consultant Radiologist Freeman Hospital This document is intended as a guide to aid radiologists and clinicians
More informationPersonal Profile. Name: 劉 XX Gender: Female Age: 53-y/o Past history. Hepatitis B carrier
Personal Profile Name: 劉 XX Gender: Female Age: 53-y/o Past history Hepatitis B carrier Chief complaint Fever on and off for 2 days Present illness 94.10.14 Sudden onset of epigastric pain 94.10.15 Fever
More informationCholangiocarcinoma (Bile Duct Cancer)
Cholangiocarcinoma (Bile Duct Cancer) The Bile Duct System (Biliary Tract) A network of bile ducts (tubes) connects the liver and the gallbladder to the small intestine. This network begins in the liver
More informationWorkup of a Solid Liver Lesion
Workup of a Solid Liver Lesion Joseph B. Cofer MD FACS Chief Quality Officer Erlanger Health System Affiliate Professor of Surgery UTHSC-Chattanooga I have no financial or other relationships with any
More informationLearning Objectives. After attending this presentation, participants will be able to:
Learning Objectives After attending this presentation, participants will be able to: Describe HCV in 2015 Describe how to diagnose advanced liver disease and cirrhosis Identify the clinical presentation
More informationHepato-Pancreatico-Biliary Surgery. Dr. Ankur J. Shah. MS, DNB, MNAMS, MRCSEd (UK), FRCS (UK)
Hepato-Pancreatico-Biliary Surgery Dr. Ankur J. Shah MS, DNB, MNAMS, MRCSEd (UK), FRCS (UK) Consultant Hepato-Pancreatico-Biliary and Liver Transplant Surgeon Ansh Liver Clinic Prevention to Cure Address
More informationHepatocytes produce. Proteins Clotting factors Hormones. Bile Flow
R.J.Bailey MD Hepatocytes produce Proteins Clotting factors Hormones Bile Flow Trouble.. for the liver! Trouble for the Liver Liver Gall Bladder Common Alcohol Hep C Fatty Liver Cancer Drugs Viruses Uncommon
More informationNavigating the Biliary Tract with CT & MR: An Imaging Approach to Bile Duct Obstruction
Navigating the Biliary Tract with CT & MR: An Imaging Approach to Bile Duct Obstruction Ann S. Fulcher, MD Medical College of Virginia Virginia Commonwealth University Richmond, Virginia Objectives To
More informationHepatobiliary Disease
Hepatobiliary Disease 大林慈濟綜合醫院 魏昌國 一般外科 Cholelithiasis 膽道結石 Incidence (USA) 10% in adult 85% cholesterol stones 15% pigment stone Risk factors Cholesterol stones Age Female(2x, 25% versus 12% at age 60),
More informationTumor incidence varies significantly, depending on geographical location.
Hepatocellular carcinoma is the 5 th most common malignancy worldwide with male-to-female ratio 5:1 in Asia 2:1 in the United States Tumor incidence varies significantly, depending on geographical location.
More informationLiver Cancer And Tumours
Liver Cancer And Tumours What causes liver cancer? Many factors may play a role in the development of cancer. Because the liver filters blood from all parts of the body, cancer cells from elsewhere can
More informationCBD stones & strictures (Obstructive jaundice)
1 CBD stones & strictures (Obstructive jaundice) Dr. Muhammad Shamim FCPS (Pak), FACS (USA), FICS (USA), MHPE (Nl & Eg) Assistant Professor, Dept. of Surgery College of Medicine, Prince Sattam bin Abdulaziz
More informationAlice Fung, MD Oregon Health and Science University
Alice Fung, MD Oregon Health and Science University Disclosure Comments The speaker Alice Fung, MD Has relevant financial relationships to disclose. Received honorarium from (Guerbet). This individual
More informationCase 1. Intro to Gallbladder & Pancreas Pathology. Case 1 DIAGNOSIS??? Acute Cholecystitis. Acute Cholecystitis. Helen Remotti M.D.
Cholecystitis acute chronic Gallbladder tumors Adenomyoma (benign) Adenocarcinoma Pancreatitis acute chronic Pancreatic tumors Intro to Gallbladder & Pancreas Pathology Helen Remotti M.D. Case 1 70 year
More informationDISEASE LEVEL MEDICAL EVIDENCE PROTOCOL
DISEASE LEVEL MEDICAL EVIDENCE PROTOCOL 1. This Protocol sets out the medical evidence that must be delivered to the Administrator for proof of Disease Level. It is subject to such further and other Protocols
More informationBackground. RUQ Ultrasound Normal, Recommend Clinical Correlation. Sohail R. Shah, MD, MSHA, FACS, FAAP Texas Children s Hosptial
RUQ Ultrasound Normal, Recommend Clinical Correlation Sohail R. Shah, MD, MSHA, FACS, FAAP Texas Children s Hosptial Background Incidence of pediatric gallbladder disease continues to rise U.S. Pediatric
More informationLiver Cancer (Hepatocellular Carcinoma or HCC) Overview
Liver Cancer (Hepatocellular Carcinoma or HCC) Overview Recent advances in liver cancer care seek to address the rising incidence of liver cancer, which has steadily increased over the past three decades.
More informationHepatocellular Carcinoma: A major global health problem. David L. Wood, MD Interventional Radiology Banner Good Samaritan Medical Center
Hepatocellular Carcinoma: A major global health problem David L. Wood, MD Interventional Radiology Banner Good Samaritan Medical Center Hepatocellular Carcinoma WORLDWIDE The #2 Cancer Killer Overall cancer
More informationSteps in Assessing Fibrosis 4/30/2015. Overview of Liver Disease Associated With HCV
Overview of Liver Disease Associated With HCV Marion G. Peters, MD John V. Carbone, Endowed Chair Professor of Medicine Chief of Hepatology Research University of California San Francisco San Francisco,
More informationManagement of Colorectal Liver Metastases
Management of Colorectal Liver Metastases MM Bernon, JEJ Krige HPB Surgical Unit, Groote Schuur Hospital Department of Surgery, University of Cape Town 50% of patients with colorectal cancer develop liver
More informationCase 1- B.N. 66 yr old F with PMHx of breast cancer s/ p mastectomy, HTN, DM presented with dysphagia to solids and liquids.
Case 1- B.N 66 yr old F with PMHx of breast cancer s/ p mastectomy, HTN, DM presented with dysphagia to solids and liquids. Reports retching to clear esophagus. Case 1- B.N EGD: Stricture in the distal
More informationEASL-EORTC Guidelines
Pamplona, junio de 2008 CLINICAL PRACTICE GUIDELINES: PARADIGMS IN MANAGEMENT OF HCC EASL-EORTC Guidelines Bruno Sangro Clínica Universidad de Navarra. CIBERehd. Pamplona, Spain Levels of Evidence according
More informationEnd Stage Liver Disease & Disease Specific Indications for Liver Transplant. Susan Kang, RN, MSN, ANP-BC
End Stage Liver Disease & Disease Specific Indications for Liver Transplant Susan Kang, RN, MSN, ANP-BC Introduction (https://www.srtr.org) What does the liver do? STORAGE METABOLIC DETOXIFICATION SYNTHETIC
More informationEnd Stage Liver Disease & Disease Specific Indications for Liver Transplant Susan Kang, RN, MSN, ANP BC
End Stage Liver Disease & Disease Specific Indications for Liver Transplant Susan Kang, RN, MSN, ANP BC Introduction (https://www.srtr.org) 1 What does the liver do? STORAGE METABOLIC DETOXIFICATION SYNTHETIC
More informationCirrhosis and Portal Hypertension Gastroenterology Teaching Project American Gastroenterological Association
CIRRHOSIS AND PORTAL HYPERTENSION Cirrhosis and Portal Hypertension Gastroenterology Teaching Project American Gastroenterological Association WHAT IS CIRRHOSIS? What is Cirrhosis? DEFINITION OF CIRRHOSIS
More informationLIVER SURGERY 2. Case 1. Med 5 Refresher Course (Surgery) 2013/14. Dr Sunny Cheung
LIVER SURGERY 2 Med 5 Refresher Course (Surgery) 2013/14 24 Jun 2013 Dr Sunny Cheung Case 1 50/M Sudden onset of epigastric pain Abdominal distension Confused HR 120 BP 80/50 Haemocue = 8 What should you
More informationNoncalculous Biliary Disease Dean Abramson, M.D. Gastroenterologists, P.C. Cedar Rapids. Cholestasis
Noncalculous Biliary Disease Dean Abramson, M.D. Gastroenterologists, P.C. Cedar Rapids Cholestasis Biochemical hallmark Impaired bile flow from liver to small intestine Alkaline phosphatase is primary
More informationERCP / PTC Surgical Laparoscopic vs open Timing and order of approach
Choledocholithiasis Which Approach and When? Lygia Stewart, MD University of California, San Francisco 2010 Naffziger Post-Graduate Course Clinical Manifestations of Choledocholithiasis Asymptomatic (no
More informationCHOLANGIOCARCINOMA (CCA)
CHOLANGIOCARCINOMA (CCA) Deepak Hariharan MD (Research), FRCS, Locum Consultant HPB Surgeon AIM Outline essential facts & principles Present 4 cases Discuss Challenges /Controversies INTRODUCTION Most
More informationThe Focal Hepatic Lesion: Radiologic Assessment
The Focal Hepatic Lesion: Radiologic Assessment Kevin Kuo, Harvard Medical School Year III Our Patient: PS 67 y/o female w/ long history of alcohol use Drinking since age 18, up to one bottle of wine/day
More informationWhat to do and not do before seeking surgical consultation for a patient with suspected pancreatic cancer
What to do and not do before seeking surgical consultation for a patient with suspected pancreatic cancer 9 Th Annual Symposium on Gastrointestinal Cancers, St. Louis University School of Medicine Carlos
More informationHilar cholangiocarcinoma. Frank Wessels, Maarten van Leeuwen, UMCU utrecht
Hilar cholangiocarcinoma Frank Wessels, Maarten van Leeuwen, UMCU utrecht Content Anatomy Biliary strictures (Hilar) Cholangiocarcinoom Staging Biliary tract 1 st order Ductus hepatica dextra Ductus hepaticus
More informationGASTROINTESTINAL MALIGNANCIES
Outline GASTROINTESTINAL MALIGNANCIES Bassel F. El-Rayes Winship Cancer Institute Emory University Colorectal Cancer Pancreas Cancer Gastric Cancer Hepatobiliary Cancer Anal Cancer Introduction Epidemiology
More informationCholangiocellular carcinoma. Dr. med. Henrik Csaba Horváth PhD
Cholangiocellular carcinoma Dr. med. Henrik Csaba Horváth PhD Acalculous biliary diseases April 12, 2017 2 Cholangiocarcinoma A slow growing malignancy of the biliary tract which tend - to infiltrate locally
More informationSurveillance for Hepatocellular Carcinoma
Surveillance for Hepatocellular Carcinoma Marion G. Peters, MD John V. Carbone, MD, Endowed Chair Professor of Medicine Chief of Hepatology Research University of California San Francisco Recorded on April
More informationGallstones & Other Biliary Disorders
Gallstones & Other Biliary Disorders Jason Smith MD DMI FRCS(Gen.Surg) Consultant General & Colorectal Surgeon Introduction Gallstones are found in 12% men and 24% women Prevalence increases with advancing
More informationMAKING CONNECTIONS. Los Angeles Medical Center
MAKING CONNECTIONS Los Angeles Medical Center Resident: Chris Molloy, MD Fellow: Christian Coroian, MD, MBA Attending: Tina Hardley, MD Program/Dept(s): Los Angeles Medical Center CHIEF COMPLAINT & HPI
More informationIMAGING OF LIVER, BILIARY TREE, PANCREAS
IMAGING OF LIVER, BILIARY TREE, PANCREAS Department of Radiology West China Hospital, Sichuan University Yao Jin Learning Points The methodology for imaging the LBP (liver, biliary tree, and pancreas )
More informationWhat is Liver Cancer? About the Liver
Your liver is important and it has many functions. The top three are that it cleans your blood of toxins, gives you energy and produces bile for digestion. What is Liver Cancer? Cancer starts when cells
More informationPancreas Case Scenario #1
Pancreas Case Scenario #1 An 85 year old white female presented to her primary care physician with increasing abdominal pain. On 8/19 she had a CT scan of the abdomen and pelvis. This showed a 4.6 cm mass
More informationApproach to Liver Lesions. Anjana A. Pillai, MD Associate Professor of Medicine Director, Liver Tumor Clinic The University of Chicago Medical Center
Approach to Liver Lesions Anjana A. Pillai, MD Associate Professor of Medicine Director, Liver Tumor Clinic The University of Chicago Medical Center Objectives Identify common clinical features and imaging
More informationAfternoon Session Cases
Afternoon Session Cases Case 1 19 year old woman Presented with abdominal pain to community hospital Mild incr WBC a14, 000, Hg normal, lipase 100 (normal to 75) US 5.2 x 3.7 x 4 cm mass in porta hepatis
More informationBile Duct Injury during Lap Chole. Bile Duct Injury during cholecystectomy TOPICS. 1. Prevalence, mechanisms, prevention and diagnosis
Bile Duct Injury during cholecystectomy Catherine HUBERT Jean-Fran François GIGOT Benoît t NAVEZ Division of Hepato-Biliary Biliary-Pancreatic Surgery Department of Abdominal Surgery and Transplantation
More informationBiliary tree dilation - and now what?
Biliary tree dilation - and now what? Poster No.: C-1767 Congress: ECR 2012 Type: Educational Exhibit Authors: I. Ferreira, A. B. Ramos, S. Magalhães, M. Certo; Porto/PT Keywords: Pathology, Diagnostic
More informationCholangiocarcinoma: Radiologic evaluation and interventions
November 2014 Cholangiocarcinoma: Radiologic evaluation and interventions Colin Nevins, Harvard Medical School Year III Agenda Initial course and work-up Endoscopic retrograde cholangiopancreatography
More informationEvaluation of Liver Mass Lesions. American College of Gastroenterology 2013 Regional Postgraduate Course
Evaluation of Liver Mass Lesions American College of Gastroenterology 2013 Regional Postgraduate Course Lewis R. Roberts, MB ChB, PhD Division of Gastroenterology and Hepatology Mayo Clinic College of
More informationEnd-Stage Liver Disease (ESLD): A Guide for HIV Physicians
Slide 1 of 32 End-Stage Liver Disease (ESLD): A Guide for HIV Physicians Marion G. Peters, MD John V. Carbone, MD, Endowed Chair Professor of Medicine Chief of Hepatology Research University of California
More informationManagement of biliary injury after laparoscopic cholecystectomy N. Dayes Kings County Hospital Center & Long Island College Hospital 8/19/2010
Management of biliary injury after laparoscopic cholecystectomy N. Dayes Kings County Hospital Center & Long Island College Hospital 8/19/2010 Case Presentation 30 y.o. woman with 2 weeks of RUQ abdominal
More informationGASTROINTESTINAL IMAGING STUDY GUIDE
GASTROINTESTINAL IMAGING STUDY GUIDE Pharynx Diverticula Foreign bodies Trauma o Motility Disorders Esophagus Diverticula Trauma Esophagitis Barrett esophagus Rings, webs, and strictures Varices Benign
More informationLiver Transplantation Evaluation: Objectives
Liver Transplantation Evaluation: Essential Work-Up Curtis K. Argo, MD, MS VGS/ACG Regional Postgraduate Course Williamsburg, VA September 13, 2015 Objectives Discuss determining readiness for transplantation
More informationBiliary Tract Disease. Emmet Andrews Cork University Hospital 6 th September 2010
Biliary Tract Disease Emmet Andrews Cork University Hospital 6 th September 2010 Overview Gallstones Biliary tract tumours Other conditions Acute acalculous cholecystitis Mirizzi s syndrome Primary Biliary
More informationBILIARY TRACT & PANCREAS, PART II
CME Pretest BILIARY TRACT & PANCREAS, PART II VOLUME 41 1 2015 A pretest is mandatory to earn CME credit on the posttest. The pretest should be completed BEFORE reading the overview. Both tests must be
More informationAppendix 5. EFSUMB Newsletter. Gastroenterological Ultrasound
EFSUMB Newsletter 87 Examinations should encompass the full range of pathological conditions listed below A log book listing the types of examinations undertaken should be kept Training should usually
More informationHepatocellular Carcinoma HCC Updated November 2015 by: Dr. Mohammed Alghamdi (Medical Oncology Fellow, University of Calgary)
Hepatocellular Carcinoma HCC Updated November 2015 by: Dr. Mohammed Alghamdi (Medical Oncology Fellow, University of Calgary) Staff Reviewers: Dr. Yoo Joung Ko (Medical Oncologist, Sunnybrook Odette Cancer
More informationThe Fellowship Council And The American Hepato-Pancreatico Biliary Association
The Fellowship Council And The American Hepato-Pancreatico Biliary Association Advanced GI Surgery Curriculum for Hepato-Pancreatic & Biliary Surgery Fellowship 1. Introduction The purpose of Fellowship
More informationCase Scenario 1. Discharge Summary
Case Scenario 1 Discharge Summary A 69-year-old woman was on vacation and noted that she was becoming jaundiced. Two months prior to leaving on that trip, she had had a workup that included an abdominal
More informationPodcast (Video Recorded Lecture Series): Portal HTN and Derivatives for the USMLE Step One Exam. Ultrasound (w/ doppler) Reversal of flow Portal Vein
Podcast (Video Recorded Lecture Series): Portal HTN and Derivatives for the USMLE Step One Exam Hepatic Vein (Budd Chiari) Ultrasound (w/ doppler) Reversal of flow Portal Vein Howard J. Sachs, MD www.12daysinmarch.com
More informationDr Claire Smith, Consultant Radiologist St James University Hospital Leeds
Dr Claire Smith, Consultant Radiologist St James University Hospital Leeds Imaging in jaundice and 2ww pathway Image protocol Staging Limitations Pancreatic cancer 1.2.4 Refer people using a suspected
More informationCurrent Treatment of Colorectal Metastases. Dr. Thavanathan Surgical Grand Rounds February 1, 2005
Current Treatment of Colorectal Metastases Dr. Thavanathan Surgical Grand Rounds February 1, 2005 25% will have metastases at initial presentation 25-50% 50% will develop metastases later 40% of potentially
More informationTranjugular Intrahepatic Portosystemic Shunt
Tranjugular Intrahepatic Portosystemic Shunt Christopher Selhorst July 25, 2005 BIDMC Radiology Overview Portal Hypertension Indications, Contraindications The Procedure Case Review Complications Outcomes
More information6 th August 2018 Day 1 - Gallbladder & Bile duct Topic
Venue: Sterling Hospital Auditorium, Sterling Hospitals, Gurukul Road Ahmedabad, Gujarat 6 th August 2018 Day 1 - Gallbladder & Bile duct Registration(8:00am-8:15am) Inauguration(8:15am-8:30am) Welcome
More informationLiver Tumors. Patient Education. Treatment options 8 4A. About the Liver. Surgical Specialties
Patient Education Treatment options This handout describes different kinds of tumors that form in the liver and how they are treated. About the Liver Your liver is the largest organ in your abdomen. It
More informationRokitansky-Aschoff sinuses are epithelial invaginations in the gallbladder wall that from as a result of increased gallbladder pressures.
Anatomy The complexity of the biliary tree can be broken down into much simpler segments. The intrahepatic ducts converge to form the right and left hepatic ducts which exit the liver and join to become
More informationTogether, putting patients first
The Role of a Gastroenterologist in the Diagnosis and Management of Pancreatic Cancer Sarah Jowett, Consultant Gastroenterologist Bradford Teaching Hospitals Trust Leeds Regional Study Day, 12 September
More informationHEPATIC METASTASES. We can state 3 types of metastases depending on their treatment options:
HEPATIC METASTASES 1. Definition Metastasis means the spread of cancer. Cancerous cells can separate from the primary tumor and enter the bloodstream or the lymphatic system (the one that produces, stores,
More informationState of the Art Imaging for Hepatic Malignancy: My Assignment
State of the Art Imaging for Hepatic Malignancy: My Assignment CT vs MR vs MRCP Which one to choose for HCC vs Cholangiocarcinoma What special protocols to use for liver tumors Role of PET and Duplex US
More informationESLD a Guide for HIV Physicians. Marion Peters University of California San Francisco June 2015
ESLD a Guide for HIV Physicians Marion Peters University of California San Francisco June 2015 Disclosures Honararia from Johnson and Johnson Roche Merck Gilead Spouse employee of Hoffman La Roche Natural
More informationIN THE NAME OF GOD. D r. MANIJE DEZFULI AZAD UNIVERCITY OF TEHRAN BOOALI HOSPITAL INFECTIOUS DISEASES SPECIALIST
IN THE NAME OF GOD AZAD UNIVERCITY OF TEHRAN BOOALI HOSPITAL D r. MANIJE DEZFULI INFECTIOUS DISEASES SPECIALIST Acute Viral Hepatitis The Anatomy of the Liver Hepatic Physiology Liver: Largest solid organ
More informationBiliary Tree Ultrasound - In a nutshell. Pamela Parker Lead Sonographer
Biliary Tree Ultrasound - In a nutshell Pamela Parker Lead Sonographer Aims Review what we know about the biliary system Common pathologies Pitfalls Reporting tips The Nutshell Background Biliary examinations
More informationSlide 1. Slide 2. Slide 3 Pancreatic Cancer- Case #1. Endoscopic management of GI malignancy. Endoscopic approaches in GI malignancy- Agenda
Slide 1 A teaching hospital of Harvard Medical School Endoscopic management of GI malignancy Tyler Berzin MD, MS Center for Advanced Endoscopy Division of Gastroenterology Beth Israel Deaconess Medical
More informationMANAGEMENT OF LIVER CIRRHOSIS: PRACTICE ESSENTIALS AND PATIENT SELF-MANAGEMENT
MANAGEMENT OF LIVER CIRRHOSIS: PRACTICE ESSENTIALS AND PATIENT SELF-MANAGEMENT Sherona Bau, ACNP The Pfleger Liver Institute 200 UCLA Medical Plaza, Suite 214 Los Angeles, CA 90095 September 30, 2017 I
More informationHCC Imaging and Advances in Locoregional Therapy. David S. Kirsch MD Ochsner Clinic Foundation
HCC Imaging and Advances in Locoregional Therapy David S. Kirsch MD Ochsner Clinic Foundation -Nothing to disclose Hepatic Imaging Primary imaging modalities include: US CT MR Angiography Nuclear medicine
More informationLiver Ultrasound - Beyond the Basics. Pamela Parker Lead Sonographer
Liver Ultrasound - Beyond the Basics Pamela Parker Lead Sonographer Aims Review what we know about the liver Reasons for imaging Focal lesions Diffuse disease Can we do more? The Liver The Liver The Liver
More informationEndoscopic Management of Biliary Strictures. Sammy Ho, MD Director of Pancreaticobiliary Services and Endoscopic Ultrasound Montefiore Medical Center
Endoscopic Management of Biliary Strictures Sammy Ho, MD Director of Pancreaticobiliary Services and Endoscopic Ultrasound Montefiore Medical Center Malignant Biliary Strictures Etiologies: Pancreatic
More informationLiver imaging takes a step forward with Ingenia
Publication for the Philips MRI Community ISSUE 49 2013 / 2 Liver imaging takes a step forward with Ingenia Lyon South Hospital strives to move from several studies first CT, then MR or PET to using just
More informationGeneral Surgery Curriculum Royal Australasian College of Surgeons, General Surgeons Australia & New Zealand Association of General Surgeons
General Surgery Curriculum Royal Australasian College of Surgeons, General Surgeons Australia & New Zealand Association of General Surgeons MODULE TITLE: UPPER GI & HPB - HEPATIC, PANCREATIC & BILIARY
More information